Molecular identification and characterization of rifampicin-resistant Mycobacterium tuberculosis isolates by line probe assay: An approach for rapid diagnosis of multidrug-resistant tuberculosis

Letters in Applied Microbiology

Volumn 47, Issue 3, 2008, Pages 214-220

  Bicmen, C ^a,b   Gunduz, A T ^b   Coskun, M ^b   Senol, G ^b   Ozkutuk, N ^c   Cirak, A K ^b   Ozacar, R ^b  

^a Training and Research Hospital for Chest Diseases and Chest Surgery ^*  (Turkey)

^b Izmir Chest Diseases and Surgery Training Hospital   (Turkey)

^c CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Identification; Molecular genetic; Mycobacteria; Rapid techniques; Resistance

Indexed keywords

PATIENT TREATMENT; PROBES; TUBES (COMPONENTS);

IDENTIFICATION; M. TUBERCULOSIS; MOLECULAR CHARACTERIZATION; MOLECULAR GENETICS; MOLECULAR IDENTIFICATION; MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIA; MYCOBACTERIUM TUBERCULOSIS; RAPID TECHNIQUE; RESISTANCE;

DIAGNOSIS;

RIFAMPICIN;

BACTERIA; BIOASSAY; DISEASE CONTROL; DRUG PRODUCTS; GROWTH KINETICS; MUTAGENESIS;

ASSAY; BACTERIUM; DRUG RESISTANCE; IDENTIFICATION METHOD; MOLECULAR ANALYSIS; TUBERCULOSIS;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE MUTATION; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; TUBERCULOSIS; VIRUS CHARACTERIZATION;

AEGEAN ISLANDS; ANATOLIA; EURASIA; EUROPE; GREECE; SOUTHERN EUROPE; TURKEY;

CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 50449100652     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2008.02403.x     Document Type: Article

References (31)

1. Ahmad, S., Araj, G.F., Akbar, P.K., Fares, E., Chugh, T.D. Mustafa, A.S. (2000) Characterization of rpoβ mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East. Diagn Microbiol Infect Dis 38, 227 232.
2. Bartfai, Z., Somoskovi, A., Kodmon, C., Szabo, N., Puskas, E., Kosztolanyi, L., Farago, E., Mester, J. et al. (2001) Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 39, 3736 3739.
3. Bodmer, T., Zurcher, G., Imboden, P. Telenti, A. (1995) Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J Antimicrob Chemother 35, 345 348.
4. Cavusoglu, C., Hilmioglu, S., Guneri, S. Bilgic, A. (2002) Characterization of rpoβ mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol 40, 4435 4438.
5. Cavusoglu, C., Turhan, A., Akinci, P. Soyler, I. (2006) Evaluation of the Genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 44, 2338 2342.
6. CLSI 2003) Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard. CLSI (NCCLS) document M24-A. Wayne, PA, USA:CLSI
7. Cooksey, R.C., Morlock, G.P., Glickman, S. Crawford, J.T. (1997) Evaluation of a line probe assay kit for characterization of rpoβ mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 35, 1281 1283.
8. Dawson-Saunders, B. Trapp, R.G. (1994) Estimating and comparing means. In Basic and Clinical Biostatistics, 2nd edn. ed. Dawson-Saunders, B. Trapp, R.G. pp. 112 122. Norwalk, Connecticut:Appleton and Lange.
9. Drobniewski, F.A., Watterson, S.A., Wilson, S.M. Harris, G.S. (2000) A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol 49, 271 278.
10. Furin, J. (2007) The clinical management of drug-resistant tuberculosis. Curr Opin Pulm Med 13, 212 217.
11. Gonzalez, N., Torres, M.J., Aznar, J. Palomares, J.C. (1999) Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuber Lung Dis 79, 187 190.
12. Goyal, M., Shaw, R.J., Banerjee, D.K., Coker, R.J., Robertson, B.D. Young, D.B. (1997) Rapid detection of multidrug-resistant tuberculosis. Eur Respir J 10, 1120 1124.
13. Hirano, K., Abe, C. Takaashi, M. (1999) Mutations in the rpoβ gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 37, 2663 2666.
14. Innogenetics, NV (2003) Kit for the detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Catalog no: 21278 v4. Ghent, Belgium:Innogenetics NV.
15. Jureen, P., Werngren, J. Hoffner, S.E. (2004) Evaluation of the line probe assay (LiPA) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb) 84, 311 316.
16. Kathleen, D.E. (2000) Molecular diagnosis. In Mycobacteria Molecular Biology and Virulance ed. Radledge, C. Dale, J.W. pp. 161 179, Oxford, UK:Blackwell Science.
17. Koskela-Adjers, K. Katila, M.L. (2003) Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis. J Clin Microbiol 41, 1235 1239.
18. Matsiota-Bernard, P., Vrioni, G. Marinis, E. (1998) Characterization of rpoβ mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 36, 20 23.
19. Moghazeh, S.L., Pan, X., Arain, T., Stover, C.K., Musser, J.M. Kreiswirth, B.N. (1996) Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoβ mutations. Antimicrob Agents Chemother 40, 2655 2657.
20. Morgan, M., Kalantri, S., Flores, L. Pai, M. (2005) A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 28, 62.
21. Pablos-Mendez, A., Raviglione, M., Laszlo, A., Binkin, N., Rieder, H.L., Bustreo, F., Cohn, D.L., Lambregts-van et al. (1998) Global surveillance for antituberculosis drug resistance, 1994-1997. N Engl J Med 338, 1641 1649.
22. Pai, M., Kalantri, S., Pascopella, L., Riley, L.W. Reingold, A.L. (2005) Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 51, 175 187.
23. Riska, P.F., Jakops, W.R. Alland, D. (2000) Molecular determinants of drug resistance in tuberculosis. Int J Tuberc Lung Dis Suppl 4 (Suppl. 1 S4 S10.
24. Senol, G., Erbaycu, A. Ozsoz, A. (2005) Incidence of cross resistance between rifampicin and rifabutin in Mycobacterium tuberculosis strains in Izmir, Turkey. J Chemother 17, 380 384.
25. Somoskovi, A., Song, Q., Mester, J., Tanner, C., Hale, Y.M., Parsons, L.M. Salfinger, M. (2003) Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system. J Clin Microbiol 41, 2822 2826.
26. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M.J., Matter, L., Schopfer, K. et al. (1993) Detection of rifampicin- resistance mutations in Mycobacterium tuberculosis. Lancet 341, 647 650.
27. Traore, H., Fissette, K., Bastian, I., Devleeschouwer, M. Portaels, F. (2000) Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 4, 481 484.
28. US Centers for Disease Control and Prevention (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs-worlwide, 2000-2004. MMWR 55, 301 305.
29. Viveiros, M., Leandro, C., Rodrigues, L., Almeida, J., Bettencourt, R., Couto, I., Carrilho, L., Diogo, J. et al. (2005) Direct application of the INNO-LiPA Rif.TB line-probe assay for rapid identification of Mycobacterium tuberculosis complex strains and detection of rifampin resistance in 360 smear-positive respiratory specimens from an area of high incidence of multidrug-resistant tuberculosis. J Clin Microbiol 43, 4880 4884.
30. Wide, M.M. Zhang, Y. (2004) Mechanism of drug resistance in Mycobacterium tuberculosis. Front Biosci 9, 975 992.
31. Zhang, Y. Telenti, A. (2000) Genetics of drug resistance in Mycobacterium tuberculosis. In Molecular Genetics of Mycobacteria ed. Hatful, G.F. Jacobs, W.R. Jr. pp. 235 254. Washington D.C.:ASM Press.